LOS ANGELES, April 29, 2011 /PRNewswire/ — UBM Canon’s Medical
Design Excellence Awards has announced the winner of the
Medical Design Excellence Awards (MDEA)
Lifetime Achievement Award. This award honors an
individual whose contributions during a long career have had a
demonstrable impact on technological, business, and cultural
advancements in medical devices.
Selected by the entire UBM Canon Medical Content Team and the Medical Device and Diagnostic
Industry Editorial Advisory Board,
Alfred E. Mann, Chairman and CEO of MannKind
Corporation, has been chosen as this award’s first recipient.
Mr. Mann has dedicated the past 42 years to the development
medical device technologies. His current company, MannKind
Corporation, is a diversified biopharmaceutical company focused on
the development of novel therapeutics and
drug delivery technologies for treatment of diabetes, cancer,
autoimmune and inflammatory diseases. MannKind’s lead
product, AFREZZA, mimics the insulin kinetics of a normal pancreas,
creating a new therapy paradigm for diabetes.
Mr. Mann stated, “I’m really honored to receive this award. Over
my career, I’ve received a number of awards but this one is
especially important because it’s associated with